Glossary

Screen failure rate

The share of patients who sign consent and start screening but do not qualify for randomization, usually because a protocol criterion is not met.

Last updated Sep 21, 20263 sources
Book a demo

What does Screen failure rate mean in clinical research?

ICH and CDISC define a screen failure as a potential participant who does not meet the eligibility (inclusion or exclusion) criteria during the screening period.⁠[1] The screen failure rate is the number of screen failures divided by everyone screened. Sponsors compare sites on it because each failure costs a visit, coordinator time and often a reimbursed procedure, with nothing to show for it.

Rates vary widely with the protocol. In the SYMPLICITY HTN-3 resistant hypertension trial, 880 of 1,415 patients screened (62%) did not meet criteria for randomization, mostly on the blood pressure entry threshold.⁠[2] In an audit of 15 randomized oncology studies at a cancer center in India, 51% of screened patients failed screening, most often for not meeting inclusion criteria.⁠[3]

Practical note: many failures are knowable from the chart before the patient comes in, such as an excluded medication, an old lab outside the window or a documented comorbidity. Screening the full record first, including notes, is the job of Identify; see the guide to reducing screen failure.

Sources

  1. 1.NCI Thesaurus C49628: Trial Screen Failure (ICH and CDISC definitions) · National Cancer Institute EVS / CDISC, 2026Quote: "The potential participant who does not meet eligibility (inclusion/exclusion) criteria during the screening period."
  2. 2.High screen failure rate in patients with resistant hypertension: Findings from SYMPLICITY HTN-3 · American Heart Journal, via PubMed, 2017Quote: "Among 1,415 patients screened, 880 (62%) did not meet criteria for randomization."
  3. 3.Audit of screen failure in 15 randomised studies from a low and middle-income country · ecancermedicalscience, via PubMed, 2022Single center (Tata Memorial Centre, India). Quote: "Out of these, 3,666 (49.0%) patients were enrolled into trials and 3,815 (51.0%) screen failed. The most common reason for screen failure was 'not meeting inclusion criteria' (54.9%) followed by declining to take treatment (22.2%)."

Related pages

Ready to get started?

Enroll patients faster.

See how Bond can accelerate enrollment for your clinical trials with a personalized demo.

Book a demo

Up to 3×

faster enrollment

90%+

matching accuracy

4-6 wks

implementation